Contains per ml:
Buparvaquone 50 mg
Bupaject Inj. is a clear, ruby-red solution for intramuscular injection and contains buparvaquone as active ingredient.
Buparvaquone is analogue of antimalarial hydroxy-naphtho-quinones. It has in vivo and in vitro antiprotozoal activity.
Bupaject Inj. is indicated for the treatment of theileriosis (Corridor disease, East Coast Fever, Tropical Theileriosis, etc.) in cattle caused by Theileria annulata and T. orientalis (sergenti). It is active against both the schizont and piroplasm stages of Theileria species and may be used in the incubation period of the disease, or when clinical signs are apparent.
Do not use subcutaneously or intravenously. Theileriosis has severe depressant effects on the immune system. Therefore, it is recommended that any vaccinations be delayed until the animal has recovered.
Localised, painless, oedematous swelling may occasionally be seen at the injection site.
Dosage and administration
For intramuscular injection into the muscles of the neck only.
Cattle : 1 ml per 20 kg bodyweight (2.5 mg buparvaquone per kg). A single injection is usually sufficient.
In severe cases, a further treatment with Bupaject Inj. at the same dose of 1 ml per 20 kg b.w. may be required (normally within 2 – 3 days after the initial injection).
No more than 10 ml should be injected into a single site.
Meat : 42 days
Milk : 48 hours
Store in a dry, dark place between 15 °C and 25 °C.
Keep medicine away from children.
50 ml multidose vial packed in individual box (105 vials per box).